OPPM

Opus Point Partners Management Portfolio holdings

AUM $46.9M
This Quarter Return
-4.19%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$104M
AUM Growth
+$141K
Cap. Flow
+$7.78M
Cap. Flow %
7.48%
Top 10 Hldgs %
45.14%
Holding
61
New
12
Increased
25
Reduced
1
Closed
5

Top Buys

1
ALNY icon
Alnylam Pharmaceuticals
ALNY
$1.64M
2
TSRO
TESARO, Inc.
TSRO
$1.35M
3
CLVS
Clovis Oncology, Inc.
CLVS
$1.33M
4
BMY icon
Bristol-Myers Squibb
BMY
$837K
5
SCTL
Societal CDMO, Inc. Common Stock
SCTL
$322K

Top Sells

1
SDS icon
ProShares UltraShort S&P500
SDS
$656K
2
CPHD
Cepheid Inc
CPHD
$315K
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$311K
4
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
$208K
5
NVAX icon
Novavax
NVAX
$54K

Sector Composition

1 Healthcare 75.87%
2 Real Estate 0.79%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PCRX icon
26
Pacira BioSciences
PCRX
$1.22B
$1.62M 1.29%
50,000
– –
TSRO
27
DELISTED
TESARO, Inc.
TSRO
$1.35M 1.07%
+10,000
New +$1.35M
CLVS
28
DELISTED
Clovis Oncology, Inc.
CLVS
$1.33M 1.06%
+30,000
New +$1.33M
PRTK
29
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.23M 0.98%
80,000
– –
ADMS
30
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$1.01M 0.81%
60,000
– –
MDCO
31
DELISTED
Medicines Co
MDCO
$950K 0.76%
28,000
– –
SNR
32
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$819K 0.65%
83,700
– –
RARE icon
33
Ultragenyx Pharmaceutical
RARE
$3.04B
$764K 0.61%
10,864
+3,790
+54% +$267K
PTLA
34
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$561K 0.45%
25,000
– –
CFRX
35
DELISTED
ContraFect Corporation
CFRX
$525K 0.42%
375
– –
LABU icon
36
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$727M
$448K 0.36%
715
-17
-2% -$10.7K
SCTL
37
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$322K 0.26%
+44,600
New +$322K
ACAD icon
38
Acadia Pharmaceuticals
ACAD
$4.34B
$290K 0.23%
+10,042
New +$290K
UTHR icon
39
United Therapeutics
UTHR
$17.7B
$280K 0.22%
1,951
+183
+10% +$26.3K
IOVA icon
40
Iovance Biotherapeutics
IOVA
$800M
$271K 0.22%
38,947
+15,353
+65% +$107K
GRFS icon
41
Grifois
GRFS
$6.53B
$267K 0.21%
16,613
+4,764
+40% +$76.6K
LGND icon
42
Ligand Pharmaceuticals
LGND
$3.25B
$263K 0.21%
+4,150
New +$263K
IQV icon
43
IQVIA
IQV
$31.4B
$260K 0.21%
3,418
+688
+25% +$52.3K
TECH icon
44
Bio-Techne
TECH
$8.3B
$254K 0.2%
+9,868
New +$254K
CRL icon
45
Charles River Laboratories
CRL
$7.99B
$252K 0.2%
+3,303
New +$252K
GILD icon
46
Gilead Sciences
GILD
$140B
$244K 0.19%
+3,408
New +$244K
KITE
47
DELISTED
Kite Pharma, Inc.
KITE
$241K 0.19%
+5,367
New +$241K
PGEN icon
48
Precigen
PGEN
$1.42B
$240K 0.19%
+9,964
New +$240K
AVXS
49
DELISTED
AveXis, Inc. Common Stock
AVXS
$239K 0.19%
+5,000
New +$239K
NBIX icon
50
Neurocrine Biosciences
NBIX
$13.5B
$238K 0.19%
6,137
+2,069
+51% +$80.2K
1
2
3